About: ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $89.55 (+0.94%)
ABVX NASDAQ Abivax SA American Depositary Shares
Abivax SA American Depositary Shares share price
ABVX price activity
Last Price
$89.550
Change (24hr)
0.84 USD (0.94%)
Volume
549.21K
Volume (4w avg)
-
Open
$90.60
Day Range
$87.79 - $90.87
Previous Close
$88.71
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
ABVX price performance
Delayed
04 Nov, 9:00 pm GMT+0
ABVX details
ABVX Market Signals